Skip to main content
Article thumbnail
Location of Repository

The protein Nα-terminal acetyltransferase hNaa10p (hArd1) is phosphorylated in HEK293 cells

By Hiwa Målen, Johan R Lillehaug and Thomas Arnesen
Topics: Short Report
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2654568
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2008). Aldabe R: Implication of human N-alpha-acetyltransferase 5 in cellular proliferation and carcinogenesis. Oncogene
    2. (2005). B: Analysis of ARD1 function in hypoxia response using retroviral RNA interference.
    3. (2003). Camussi G: CD40-dependent activation of phosphatidylinositol 3-kinase/Akt pathway mediates endothelial cell survival and in vitro angiogenesis.
    4. (2000). Eckerskorn C: Deamidation as a widespread phenomenon in two-dimensional polyacrylamide gel electrophoresis of human blood plasma proteins. Electrophoresis
    5. (2003). ELM server: A new resource for investigating short functional sites in modular eukaryotic proteins. Nucleic Acids Res
    6. (2006). Fersht AR: Characterization of the native and fibrillar conformation of the human Nalpha-acetyltransferase ARD1. Protein Sci
    7. (2008). Identification of the human N(alpha)-acetyltransferase complex B (hNatB): a complex important for cellcycle progression. Biochem J
    8. (2006). Lillehaug JR: Characterization of hARD2, a processed hARD1 gene duplicate, encoding a human protein N-alpha-acetyltransferase.
    9. (2006). Lillehaug JR: Induction of apoptosis in human cells by RNAi-mediated knockdown of hARD1 and NATH, components of the protein N-alpha-acetyltransferase complex. Oncogene
    10. (2003). N-terminal acetyltransferases and sequence requirements for N-terminal acetylation of eukaryotic proteins.
    11. (2003). RS: Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol Sci
    12. (2002). S: Mechanisms of action of arsenic trioxide. Cancer Res
    13. (2005). T: Interaction of N-terminal acetyltransferase with the cytoplasmic domain of beta-amyloid precursor protein and its effect on A beta secretion.
    14. (2002). Vidal-Puig A: Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45. Biochem Biophys Res Commun
    15. (2006). YS: Human arrest defective 1 acetylates and activates beta-catenin, promoting lung cancer cell proliferation. Cancer Res

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.